CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Boston MA, New Haven CT, Manhasset NY, Rosedale NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
Interested in new transthyretin amyloid cardiomyopathy trials?
Get alerts for new trials in your area by subscribing now
Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy
for
Amyloid Cardiomyopathy
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sex: All
Age: 40 - 70+
Code: NCT06634108
Phase1, Phase2, Recruiting
New
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
for
Transthyretin Amyloidosis,
Location: Vancouver, Los Angeles CA
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07654855
Recruiting
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
for
Transthyretin Amyloidosis, Heart Failure,
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 65+
Code: NCT05577819
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant